BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31082679)

  • 1. Generation of an iPSC line from a retinitis pigmentosa patient carrying a homozygous mutation in CERKL and a healthy sibling.
    Bolinches-Amorós A; León M; Del Buey Furió V; Marfany G; Gonzàlez-Duarte R; Erceg S; Lukovic D
    Stem Cell Res; 2019 Jul; 38():101455. PubMed ID: 31082679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of an induced pluripotent stem cell (iPSC) line from a patient with autosomal dominant retinitis pigmentosa due to a mutation in the NR2E3 gene.
    Terray A; Slembrouck A; Nanteau C; Chondroyer C; Zeitz C; Sahel JA; Audo I; Reichman S; Goureau O
    Stem Cell Res; 2017 Oct; 24():1-4. PubMed ID: 29034877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of an induced pluripotent stem cell line (FRIMOi005-A) derived from a retinitis pigmentosa patient carrying a dominant mutation in RHO gene.
    Domingo-Prim J; Riera M; Burés-Jelstrup A; Corcostegui B; Pomares E
    Stem Cell Res; 2019 Jul; 38():101468. PubMed ID: 31146251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a human iPSC line from a patient with retinitis pigmentosa caused by mutation in PRPF8 gene.
    Lukovic D; Bolinches-Amorós A; Artero-Castro A; Pascual B; Carballo M; Hernan I; Erceg S
    Stem Cell Res; 2017 May; 21():23-25. PubMed ID: 28677533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of gene-corrected human induced pluripotent stem cell lines derived from retinitis pigmentosa patient with Ser331Cysfs*5 mutation in MERTK.
    Artero Castro A; Long K; Bassett A; Machuca C; León M; Ávila-Fernandez A; Cortón M; Vidal-Puig T; Ayuso C; Lukovic D; Erceg S
    Stem Cell Res; 2019 Jan; 34():101341. PubMed ID: 30612079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of an induced pluripotent stem cell line (FRIMOi002-A) from a retinitis pigmentosa patient carrying compound heterozygous mutations in USH2A gene.
    Riera M; Patel A; Corcostegui B; Chang S; Corneo B; Sparrow JR; Pomares E
    Stem Cell Res; 2019 Mar; 35():101386. PubMed ID: 30685615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of two human iPSC lines from patients with autosomal dominant retinitis pigmentosa (UCLi014-A) and autosomal recessive Leber congenital amaurosis (UCLi015-A), associated with RDH12 variants.
    Sarkar H; Méjécase C; Harding P; Eintracht J; Toualbi L; Cunha DL; Moosajee M
    Stem Cell Res; 2021 Jul; 54():102449. PubMed ID: 34216980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CERKL mutations and associated phenotypes in seven Spanish families with autosomal recessive retinitis pigmentosa.
    Avila-Fernandez A; Riveiro-Alvarez R; Vallespin E; Wilke R; Tapias I; Cantalapiedra D; Aguirre-Lamban J; Gimenez A; Trujillo-Tiebas MJ; Ayuso C
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2709-13. PubMed ID: 18515597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and characterization of an iPSC line (FRIMOi001-A) derived from a retinitis pigmentosa patient carrying PDE6A mutations.
    Riera M; Patel A; Corcostegui B; Chang S; Sparrow JR; Pomares E; Corneo B
    Stem Cell Res; 2019 Mar; 35():101385. PubMed ID: 30685614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of three human iPSC lines from a retinitis pigmentosa family with SLC7A14 mutation.
    Li YP; Liu H; Jin ZB
    Stem Cell Res; 2020 Dec; 49():102075. PubMed ID: 33207307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of CERKL, a gene responsible for retinitis pigmentosa in humans, protects cells from apoptosis induced by oxidative stress.
    Tuson M; Garanto A; Gonzàlez-Duarte R; Marfany G
    Mol Vis; 2009; 15():168-80. PubMed ID: 19158957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of CERKL, a novel human ceramide kinase gene, causes autosomal recessive retinitis pigmentosa (RP26).
    Tuson M; Marfany G; Gonzàlez-Duarte R
    Am J Hum Genet; 2004 Jan; 74(1):128-38. PubMed ID: 14681825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of an induced pluripotent stem cell line from a patient with retinitis pigmentosa caused by RP1 mutation.
    Zhang X; Moon SY; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; McLenachan S; Chen FK
    Stem Cell Res; 2019 May; 37():101452. PubMed ID: 31059986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CERKL mutation causing retinitis pigmentosa(RP) in Indian population - a genotype and phenotype correlation study.
    Sen P; Maitra P; Natarajan S; Sripriya S; Mathavan S; Bhende M; Manchegowda PT
    Ophthalmic Genet; 2020 Dec; 41(6):570-578. PubMed ID: 32865075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a human iPS cell line from a patient with retinitis pigmentosa due to EYS mutation.
    Calado SM; Garcia-Delgado AB; De la Cerda B; Ponte-Zuñiga B; Bhattacharya SS; Díaz-Corrales FJ
    Stem Cell Res; 2018 Dec; 33():251-254. PubMed ID: 30471616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of two patient-derived iPSC lines from siblings (LIBUCi001-A and LIBUCi002-A) and a genetically modified iPSC line (JMUi001-A-1) to mimic dilated cardiomyopathy with ataxia (DCMA) caused by a homozygous DNAJC19 mutation.
    Janz A; Chen R; Regensburger M; Ueda Y; Rost S; Klopocki E; Günther K; Edenhofer F; Duff HJ; Ergün S; Gerull B
    Stem Cell Res; 2020 Jul; 46():101856. PubMed ID: 32521499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of an iPSC line, INMi001-A, carrying the two most common USH2A mutations from a compound heterozygote with non-syndromic retinitis pigmentosa.
    Sanjurjo-Soriano C; Erkilic N; Manes G; Dubois G; Hamel CP; Meunier I; Kalatzis V
    Stem Cell Res; 2018 Dec; 33():228-232. PubMed ID: 30453153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and characterization of a human iPSC line (UAMi004-A) from a patient with propionic acidemia due to defects in the PCCB gene.
    López-Márquez A; Alonso-Barroso E; Cerro-Tello G; Bravo-Alonso I; Arribas-Carreira L; Briso-Montiano Á; Navarrete R; Pérez-Cerdá C; Ugarte M; Pérez B; Desviat LR; Richard E
    Stem Cell Res; 2019 Jul; 38():101469. PubMed ID: 31132581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and characterization of the human iPSC line CABi001-A from a patient with retinitis pigmentosa caused by a novel mutation in PRPF31 gene.
    de la Cerda B; Díez-Lloret A; Ponte B; Vallés-Saiz L; Calado SM; Rodríguez-Bocanegra E; Garcia-Delgado AB; Moya-Molina M; Bhattacharya SS; Díaz-Corrales FJ
    Stem Cell Res; 2019 Apr; 36():101426. PubMed ID: 30921587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of two induced pluripotent stem cell lines from a retinitis pigmentosa patient with compound heterozygous mutations in CRB1.
    Moon SY; Zhang D; Chen SC; Lamey TM; Thompson JA; McLaren TL; De Roach JN; Chen FK; McLenachan S
    Stem Cell Res; 2021 Jul; 54():102403. PubMed ID: 34034222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.